Cargando…
High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas
Background: Glioma is the most common primary tumor of the central nervous system and is associated with poor overall survival, creating an urgent need to identify survival-associated biomarkers. C1ORF112, an alpha-helical protein, is overexpressed in some cancers; however, its prognostic role has n...
Autores principales: | Zhang, Zhe, Tan, Zilong, Lv, Qiaoli, Wang, Lichong, Yu, Kai, Yang, Huan, Liang, Huaizhen, Lu, Tianzhu, Ji, Yulong, Chen, Junjun, He, Wei, Chen, Zhen, Chen, Shuhui, Shen, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645850/ https://www.ncbi.nlm.nih.gov/pubmed/34880897 http://dx.doi.org/10.3389/fgene.2021.710944 |
Ejemplares similares
-
Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis
por: Zhang, Zhe, et al.
Publicado: (2023) -
Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma
por: Tan, Zilong, et al.
Publicado: (2022) -
A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021) -
High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022) -
Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma
por: Feng, Jing, et al.
Publicado: (2021)